Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma.

Journal article

Lovestone S. and Manji HK., (2020), Clin Pharmacol Ther, 107, 79 - 81

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.

Journal article

Ten Kate M. et al, (2018), Alzheimers Res Ther, 10

Heterogeneous patterns of brain atrophy in Alzheimer's disease.

Journal article

Poulakis K. et al, (2018), Neurobiol Aging, 65, 98 - 108

Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.

Journal article

Firouzian A. et al, (2018), EJNMMI Res, 8

Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons.

Journal article

Robbins JP. et al, (2018), Front Neurosci, 12

Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients

Journal article

Judge AD. et al, (2017), Alzheimer's & Dementia: Translational Research & Clinical Interventions

Effects of freezer storage time on levels of complement biomarkers.

Journal article

Morgan AR. et al, (2017), BMC Res Notes, 10

Load More